Neuropeptides < Neuroprotective Agents < Neuropsychological Tests

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]

Ident.	Authors (with country if any)	Title
000005 (2015)	Benzi Kluger [États-Unis] ; Piera Triolo ; Wallace Jones ; Joseph Jankovic [États-Unis]	The therapeutic potential of cannabinoids for movement disorders.
000024 (2014)	Joseph Jankovic [États-Unis] ; Elijahu Berkovich [Israël] ; Eli Eyal [Israël] ; Eduardo Tolosa [Espagne]	Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: post-hoc analyses from the ADAGIO trial.
000029 (2014)	Ya Feng [République populaire de Chine] ; Te Liu [République populaire de Chine] ; Xin Li [États-Unis] ; Ye Liu [République populaire de Chine] ; Xiao Zhu [République populaire de Chine] ; Joseph Jankovic [États-Unis] ; Tian Pan [États-Unis] ; Yun Wu [République populaire de Chine]	Neuroprotection by Orexin-A via HIF-1α induction in a cellular model of Parkinson's disease.
000088 (2010)	Wenjie Xie [États-Unis] ; Xuping Li ; Chao Li ; Wen Zhu ; Joseph Jankovic [États-Unis] ; Weidong Le	Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease.
000094 (2010)	Rodger. Elble [États-Unis] ; Oksana Suchowersky ; Stephanie Shaftman ; William. Weiner ; Peng Huang ; Barbara Tilley	Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease.
000110 (2009)	T. Pan [États-Unis] ; P. Rawal ; Y. Wu ; W. Xie ; Joseph Jankovic [États-Unis] ; W. Le	Rapamycin protects against rotenone-induced apoptosis through autophagy induction.
000128 (2009)	C Olanow [États-Unis] ; Olivier Rascol ; Robert Hauser ; Paul. Feigin ; Joseph Jankovic [États-Unis] ; Anthony Lang ; William Langston ; Eldad Melamed ; Werner Poewe ; Fabrizio Stocchi ; Eduardo Tolosa	A double-blind, delayed-start trial of rasagiline in Parkinson's disease.
000137 (2008)	Tianhong Pan [États-Unis] ; Seiji Kondo ; Wen Zhu ; Wenjie Xie ; Joseph Jankovic [États-Unis] ; Weidong Le	Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement.
000150 (2008)	C Olanow [États-Unis] ; Robert. Hauser ; Joseph Jankovic [États-Unis] ; William Langston ; Anthony Lang ; Werner Poewe ; Eduardo Tolosa ; Fabrizio Stocchi ; Eldad Melamed ; Eli Eyal ; Olivier Rascol	A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics.
000186 (2005)	Tianhong Pan [États-Unis] ; Xinqun Li ; Wenjie Xie ; Joseph Jankovic [États-Unis] ; Weidong Le	Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells.
000192 (2005)	C Olanow [États-Unis] ; Joseph Jankovic [États-Unis]	Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy.
000200 (2005)	Tianhong Pan [États-Unis] ; Wenjie Xie ; Joseph Jankovic [États-Unis] ; Weidong Le	Biological effects of pramipexole on dopaminergic neuron-associated genes: relevance to neuroprotection.
000210 (2003)	J Nutt [États-Unis] ; K Burchiel ; C Comella ; Joseph Jankovic [États-Unis] ; A Lang ; E Laws ; A Lozano ; R Penn ; R Simpson ; M. Stacy ; G Wooten	Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.
000211 (2003)	Tianhong Pan [États-Unis] ; Joseph Jankovic [États-Unis] ; Weidong Le	Potential therapeutic properties of green tea polyphenols in Parkinson's disease.
000212 (2003)	Nicole Simpkins [États-Unis] ; Joseph Jankovic [États-Unis]	Neuroprotection in Parkinson disease.
000219 (2003)	Ron Tintner [États-Unis] ; Joseph Jankovic [États-Unis]	Dopamine agonists in Parkinson's disease.
000232 (2002)	Joseph Jankovic [États-Unis] ; C. Hunter	A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease.
000248 (2001)	W Le [États-Unis] ; Joseph Jankovic [États-Unis]	Are dopamine receptor agonists neuroprotective in Parkinson's disease?
000259 (2000)	W Le [États-Unis] ; Joseph Jankovic [États-Unis] ; W. Xie ; S Appel	Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection.
000262 (1999)	Joseph Jankovic [États-Unis]	New and emerging therapies for Parkinson disease.
000346 (????)	Madhavi Thomas [États-Unis] ; Wei Le ; Joseph Jankovic [États-Unis]	Minocycline and other tetracycline derivatives: a neuroprotective strategy in Parkinson's disease and Huntington's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Neuroprotective Agents" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Neuroprotective Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    JankovicV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Neuroprotective Agents
}}

---

This area was generated with Dilib version V0.6.19. Data generation: Wed Feb 10 22:03:07 2016. Site generation: Tue Feb 13 16:14:27 2024